Jove
Visualize
联系我们

相关概念视频

The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

3.3K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.3K
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

180.2K
Overview
180.2K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

3.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

1.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.0K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

2.0K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.0K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

100
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
100

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Fetal factors disrupt placental and maternal iron homeostasis in murine β-thalassemia.

Blood·2023
Same author

Corrigendum: Iron and Cadmium Entry Into Renal Mitochondria: Physiological and Toxicological Implications.

Frontiers in cell and developmental biology·2021
Same author

Correction to: Iron chelation may harm patients with COVID-19.

European journal of clinical pharmacology·2021
Same author

Iron and Cadmium Entry Into Renal Mitochondria: Physiological and Toxicological Implications.

Frontiers in cell and developmental biology·2020
Same author

Iron chelation may harm patients with COVID-19.

European journal of clinical pharmacology·2020
Same author

Animal Models of Normal and Disturbed Iron and Copper Metabolism.

The Journal of nutrition·2019
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 26, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.6K

管理铁过载:一个肠道检查

Michael D Garrick1

  • 1Department of Biochemistry, University at Buffalo, Buffalo, New York mgarrick@buffalo.edu.

The Journal of pharmacology and experimental therapeutics
|June 15, 2023
PubMed
概括

双价金属转运体1 (DMT1) 抑制剂对研究铁平衡有前途,但面临毒性挑战. 需要进一步的研究,以开发安全的铁过载障碍治疗方法.

科学领域:

  • 生物化学 生物化学
  • 药理学 药理学是指药理学的学科.
  • 生理学 生理学 生理学

背景情况:

  • 二元金属转运体1 (DMT1) 对于十二指肠中铁的吸收至关重要.
  • 开发特定的DMT1抑制剂是了解铁平衡和治疗铁过载障碍的关键.
  • 挑战包括DMT1的广泛组织表达和多种金属离子的运输.

研究的目的:

  • 评估Xenon制药公司在开发DMT1抑制剂方面的努力.
  • 评估XEN601和XEN602作为研究工具的实用性.
  • 考虑治疗铁过载障碍的替代策略.

主要方法:

  • 关于DMT1抑制剂,特别是XEN601和XEN602.2的已发表研究的综述.
  • 对这些化合物的报告有效性和毒性的分析.
  • 探索替代治疗方法的探索.

主要成果:

  • 谢农制药公司开发了强大的DMT1抑制剂,XEN601和XEN602.
  • 这些抑制剂已经证明,作为研究金属离子平衡的研究工具,它们具有显著的实用性.
  • 然而,这些化合物表现出毒性,导致其治疗用途的开发停止.

更多相关视频

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

518
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.0K

相关实验视频

Last Updated: Jul 26, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.6K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

518
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.0K

结论:

  • 克森的DMT1抑制剂对研究有价值,但对于治疗由于毒性导致的铁过载障碍是不可行的.
  • 需要采用替代策略来开发安全有效的药理疗法来治疗铁过载.
  • 对DMT1功能和抑制的持续研究对于推进治疗选择至关重要.